1. Friday May 25, 2018
      Home > BUSINESS
      Text:| Print|

      Bear bile IPO bid gets little authoritative support

      2012-03-12 14:27 Xinhua     Web Editor: Zhang Chan comment

      After weeks of criticism, Chinese bear bile producer Guizhentang faces a bumpier path for going public, as discussion over its listing attempt has continued to sizzle at the country's annual legislative session but little support has been found.

      Xiao Wei, a Chinese lawmaker and an authority in the pharmaceutical industry, voiced straight opposition to the initial public offering (IPO) of Guizhentang Pharmaceutical Co. Ltd, the East China company that harvests bile from live bears to use in its products.

      It would be "inappropriate" for pharmaceutical companies that turn a profit selling bear bile to seek a listing in the capital market, said Xiao, who is a member of the Chinese Pharmacopoeia Commission and head of a state key laboratory for traditional Chinese medicine (TCM).

      "It could mean that they will extract more bile from live bears," said Xiao, who is also a deputy of the National People's Congress, China's top legislature.

      For nearly 3,000 years, bear bile has been used as an ingredient in TCM to cure eye and liver ailments.

      "I only approve of the use of bear bile in the treatment of very rare or acute diseases, but I do not think it can be used that much in common diseases," he said, adding that he believes the medical value of bear bile is "complicated and irreplaceable."

      Guizhentang has already established an industry chain, as it feeds bears for their bile, which is against international animal protection conventions, he said.

      Guizhentang has been under fire for weeks since it was found to have resumed a plan to go public to expand its bile production. The company's last IPO attempt in February 2011 floundered amid fierce public opposition.

      The bear bile producer allowed more than 100 reporters to visit its bear farm in February amid protests from the public and animal welfare activists, but this has done little to help quell criticism.

      In response to public concern, Chinese securities authorities said they have "noticed" the recent debates over bear bile products and are soliciting opinions from relevant departments on the matter.

      Zhu Congjiu, assistant chairman of the China Securities Regulatory Commission (CSRC), said the CSRC will examine Guizhentang's IPO plan after seeking opinions on whether the listing will be in line with China's industrial policies.

      In response to a similar question, Chinese Health Minister Chen Zhu said human beings should follow the principle of sustainable use of natural resources and protection over bio-diversity.

      "We have ethical principles that human beings and nature should maintain a compatible relationship, and that animals, including experimental ones, should be strictly protected," Chen said while commenting on the bear bile extraction.

      "When humans and nature have a conflict of interests, we tend to choose the lesser of two evils," he said.

      But some showed a more tough stance by calling for legislation to ban bile extraction from live bears.

      "I have been in tears since I heard of the extraction on my plane back from Hong Kong," said Feng Jicai, a well-known Chinese writer and vice-chairman of China Federation of Literary and Art Circles.

      "It is not a question whether extracting bile from live bears should be banned," said Feng, who is also a member of the National Committee of the Chinese People's Political Consultative Conference, China's top political advisory body.

      Wang Guoqiang, vice health minister and director of the State Administration of TCM, said Chinese authorities are promoting research to find for alternatives to animal-derived drugs.

      Wang said TCM authorities do not oppose public discussion on the issue, but he called on the public to approach the debate from more rational perspectives, since a substitute for bear bile has yet to be found and more work needs to be done to improve the technologies.

      Comments (0)

      Copyright ©1999-2011 Chinanews.com. All rights reserved.
      Reproduction in whole or in part without permission is prohibited.

      主站蜘蛛池模板: 天天爽亚洲中文字幕| 亚洲最新在线视频| 一级毛片aa高清免费观看| 又爽又黄无遮挡高清免费视频 | 国产区在线免费观看| 亚洲色大成WWW亚洲女子| 久久久久久久国产免费看| 亚洲精品亚洲人成在线观看下载| 亚洲AV人人澡人人爽人人夜夜| 亚洲乱人伦中文字幕无码| 国产成人精品无码免费看| 亚洲va在线va天堂va四虎| 精品无码人妻一区二区免费蜜桃 | 一个人免费日韩不卡视频| 老外毛片免费视频播放| 亚洲精品国产精品乱码视色| 亚洲va久久久噜噜噜久久男同 | 国产亚洲精品线观看动态图| 九一在线完整视频免费观看| 国产亚洲日韩一区二区三区| 亚洲成av人无码亚洲成av人| 四虎永久在线精品免费观看地址 | a级亚洲片精品久久久久久久| 怡红院免费全部视频在线视频 | 亚洲婷婷第一狠人综合精品| 在线观看免费a∨网站| 337p欧洲亚洲大胆艺术| av无码免费一区二区三区| 亚洲av福利无码无一区二区| 最近中文字幕免费完整| 亚洲风情亚Aⅴ在线发布| 亚洲一级特黄大片无码毛片 | 亚洲av永久无码精品国产精品| 91免费国产自产地址入| 亚洲码国产精品高潮在线| 九九全国免费视频| 亚洲色四在线视频观看| 精品免费国产一区二区| 成人性做爰aaa片免费看| 精品亚洲456在线播放| 国产亚洲精品a在线观看 |